Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay

DSpace Repository

Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay

Author: Schott, Sarah; Wallwiener, Markus; Kootz, Beate; Seeger, Harald; Fehm, Tanja; Neubauer, Hans
Tübinger Autor(en):
Kootz, Beate
Seeger, Harald
Fehm, Tanja
Neubauer, Hans
Published in: Investigational New Drugs (2012), Bd. 30, H. 4, S. 1750-1755
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s10637-011-9688-3
ISSN: 0167-6997
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)